ASCO Guidelines

Updated ASCO Guidelines strongly recommend use of the Oncotype DX Breast Recurrence Score® Test in node-negative and the majority of node-positive early-stage breast cancer patients

Practice-changing RxPONDER study

Results of practice-changing RxPONDER study published in The New England Journal of Medicine
Making cancer care smarter.™